Cardiovascular and Interventional Radiological Society of Europe
Slider
PublicationsCIRSE InsiderINTERACT-EUROPE 100: Encouragement from Dr. Orsi

INTERACT-EUROPE 100: Encouragement from Dr. Orsi

July 4, 2024

A new EU project, the INTERACT-EUROPE 100 initiative is recruiting 100 cancer centres across Europe to take part in an interdisciplinary training programme over the next three years. Dr. Franco Orsi represents CIRSE in the INTERACT-EUROPE 100 consortium. He wrote to us to tell us about the background of the programme and why it is imperative that centres with developed interventional oncology practices take part.


By Dr. Franco Orsi, Chief of Division of Interventional Radiology, European Institute of Oncology, Milan

The INTERACT-EUROPE 100 initiative is funded by the European Union under the EU4Health programme, an ambitious project designed to enhance the quality and accessibility of cancer care across Europe. It focuses on implementing inter-specialty cancer training, called the ISCT curriculum, in 100 oncology centres. This initiative is a follow-up to the INTERACT-EUROPE project, which developed a comprehensive training programme aimed at fostering multidisciplinary collaboration among various oncology specialties. The main goal is to create a standardized, patient-centred approach to cancer treatment by promoting teamwork and communication across different medical specialties. The INTERACT-EUROPE 100 programme expands upon this first initiative and includes new modules, such as one that focuses on paediatric oncology and one on the specific needs of displaced persons.

As a member of the INTERACT-EUROPE 100 consortium, CIRSE is an important partner in this project. Participation from centres with developed IO practices is crucial for many reasons. Practitioners from centres where IO practice is very well organized have advanced knowledge of innovative techniques and can provide a valuable contribution to the training curriculum by sharing this expertise. They can demonstrate how effectively IO techniques can be integrated within broader oncology practice, promoting a more holistic approach to cancer treatment. Established IO centres, for example, centres with IASISOS accreditation, are in a unique position and could mentor and train other centres, explaining best practices and elevating the overall standard of cancer care throughout this new network. The involvement of these centres will ensure that cutting-edge IO practices become a core part of the interdisciplinary cancer care model of this project.

Dr. Orsi presenting at ECIO 2024 earlier this year

We’ve been talking about the importance of a multidisciplinary treatment for a long time, but until now this has usually meant that different doctors talk about different ways to treat the patient, but everyone stays behind the fences of their own field. Truly interdisciplinary cancer management means that almost everyone knows how to interact with the others to make sure patients receive the best holistic treatment. At this stage, we know there are lot of gaps between different countries, and even within the same country between different hospitals. One of the aims of the project is to gain a better understanding of these gaps in order to reduce them.

I would suggest all centres with interventional oncology activities apply. This should not be limited to only centres with a very advanced department; this initiative should be of interest to all practitioners who want to enhance their interdisciplinary workflow with other disciplines. The participants in this project will have access to a cutting-edge inter-specialty cancer training curriculum and become a part of a network of 100 cancer centres. It’s the first time that we have an opportunity to be part of a huge clinical community with a focus on an interdisciplinary approach to cancer. This will facilitate collaboration and knowledge exchange on a never-before-seen scale, and it is imperative to promote the role of interventional oncology within this community.

INTERACT-EUROPE 100 is a multiyear programme; we are just the beginning. The first participating centres are selecting trainers and developing the training programme. The next step will be to deliver the training to the other centres that will apply to the programme. A lot of work has already happened behind the scenes. Connecting all the different disciplines and trying to make them “speak the same language” has not been easy, especially as involvement is not limited strictly to physicians. It also includes psychologists, nurses, and all kinds of caregivers that are involved in this field. The inclusion of these other providers and caregivers can be helpful also to interventional oncologists, as many of us have come from the radiology field and are not always trained to manage patients in clinical settings. This is a good opportunity not only to increase our role and image via-a-vis other specialties, but also to learn how to manage our patients in a better way.

I want to underline that this project, for interventional oncologists in particular, may offer a platform to refine but also to showcase our techniques. As interventional oncologists, we may gain exposure to new methodologies and we will be able to position ourselves at the forefront of integrating these practices into more comprehensive cancer care rather than remaining isolated within our hospitals, as many specialists do. This is an excellent opportunity to be part of a comprehensive community, and this is very important to us as IOs. Instead of being on the periphery of the field where everything happens, we now have the opportunity to move towards the centre as main actors in the wider field of cancer care.


Applications for the INTERACT-EUROPE 100 programme will be accepted until September 30, 2024. Click on the links below for more information and to apply for the programme.

CIRSE is a member of the INTERACT-EUROPE 100 consortium.